The narrative that GLP-1 medications are bad for the fitness industry is losing ground fast. A June 2026 white paper from the Health and Fitness Association (HFA, formerly IHRSA) makes the case plainly: structured exercise isn't optional for GLP-1 users. It's medically necessary. And that changes everything for gym operators who are paying attention.
The HFA's position is built on a growing body of clinical evidence showing that drug-induced weight loss without resistance training leads to significant lean muscle loss, reduced metabolic rate, and worse long-term health outcomes. GLP-1 medications like semaglutide are powerful. But they work best when paired with a deliberate physical training program. That pairing is your business opportunity.
Why GLP-1 Adoption Creates a High-Intent Member Segment
GLP-1 receptor agonist prescriptions have expanded well beyond their original diabetes indication. Millions of American adults are now using semaglutide or tirzepatide for weight management, and that number is accelerating. Analysts project continued double-digit growth in GLP-1 prescriptions through the late 2020s as more insurance plans cover these medications and biosimilar competition begins to lower costs.
What makes this cohort valuable to you as an operator isn't just their size. It's their mindset. GLP-1 users are medically motivated. They've made a significant commitment, financially and personally, to changing their body composition. They're not browsing for a cheap gym membership. They're looking for a structured environment that protects their investment in the drug.
Research consistently shows that people who combine GLP-1 therapy with regular resistance training preserve significantly more lean muscle mass during weight loss compared to drug-only users. That clinical reality is your pitch. You're not selling fitness. You're selling the physiological outcome their prescription alone can't deliver.
The HFA White Paper: Positioning Exercise as Essential, Not Optional
The June 2026 HFA white paper is worth understanding in detail because it gives gym operators a credible, industry-backed framework to use in their marketing and clinical partnerships. The core argument is straightforward: GLP-1 medications reduce appetite and promote caloric deficit, but they don't discriminate between fat and muscle when the body loses weight. Without targeted resistance and cardiovascular work, patients risk losing the metabolically active tissue that supports long-term weight maintenance.
The HFA frames this not as a critique of the medications but as a structural argument for why gyms belong in the GLP-1 care pathway. That's a meaningful shift. It positions fitness facilities not as lifestyle amenities but as clinical-adjacent service providers. If your facility can credibly occupy that space, you're competing in a different category than the budget gym down the street.
With 81 million Americans holding gym memberships as of 2025, according to HFA data published in April 2026, the baseline audience is already there. The question is whether you're structuring your offer to capture the GLP-1 subset specifically. If you're not, someone else will. For a broader view of where membership growth is heading, the fitness market's projected doubling by 2036 makes the case for building clinical positioning now, not later.
What GLP-1-Aligned Programming Actually Looks Like
You don't need to hire medical staff or rebrand as a health clinic to serve this population. What you need is a coherent program structure that addresses their specific physiological needs during active weight loss. That means:
- Coach-supervised strength circuits designed to preserve lean mass, typically two to three sessions per week combining compound movements with progressive overload protocols.
- Cardiovascular programming that complements rather than competes with caloric restriction, focusing on moderate-intensity steady-state work and zone-two training to support metabolic health.
- Onboarding assessments that capture body composition baselines, allowing members to track muscle preservation over time rather than just scale weight.
- Nutrition coaching add-ons that help members meet protein targets critical for muscle retention during GLP-1-assisted weight loss.
The combination of lifting and cardiovascular training is already well-supported by outcome data. Research on lifting and cardio combined shows significantly better long-term health outcomes than either modality alone, which maps directly onto what GLP-1 users need to hear when you're explaining your program's structure.
Personal training is a natural fit here. GLP-1 users are often new to structured strength training and may feel uncertain about form, load, and progression. That uncertainty is a coaching opportunity. If you're not sure how to communicate the value of professional coaching to this audience, the signals that indicate when someone genuinely needs a personal trainer are worth building into your sales conversations.
The Upsell Stack: Where the Revenue Actually Comes From
GLP-1-aligned programming isn't just a member acquisition tool. It's a revenue architecture. Medically motivated members have a demonstrated willingness to spend on services that directly support their health goals. Research published in July 2026 confirms that nutrition and meal planning coaching ranks among the highest-value add-on services gym operators can offer, and it's a direct overlap with what GLP-1 patients need.
Think about your revenue per member across a twelve-month relationship with a GLP-1 user who is actively in the weight loss phase. A base membership might run $50 to $80 per month. Add a GLP-1 strength program at $150 per month, nutrition coaching at $100 to $200 per month, and periodic body composition assessments, and you're looking at a member generating $400 or more monthly. That's the kind of average revenue per member that fundamentally changes your unit economics.
Nutrition coaching infrastructure doesn't have to be built entirely in-house. The personalized nutrition technology space is attracting serious capital, as evidenced by the $2.1M raised by Hexis for personalized nutrition applications. Partnering with or integrating platforms like these into your GLP-1 program can give you a data-backed nutrition layer without hiring a full dietitian team from day one.
Building Clinical-Adjacent Positioning Before It Becomes Standard
The fitness industry is moving toward healthcare convergence. That's not a prediction anymore. It's an operational reality that major operators are already building toward. The question for independent and mid-size gym operators is whether you position proactively or reactively.
Clinical-adjacent positioning means a few specific things in practice. It means developing referral relationships with primary care physicians, endocrinologists, and obesity medicine specialists who are prescribing GLP-1 medications. It means having a clear, professionally presented program document you can share with a clinician who asks what your facility offers their patients. It means training your coaching staff to speak the language of muscle preservation, protein adequacy, and progressive overload in terms a medically motivated client will find credible.
It also means staying current with how the coaching profession itself is evolving. Movement science is increasingly central to high-quality coaching, and coaches who understand the physiological mechanisms of GLP-1-induced weight loss will be far more effective at building trust with this member segment.
The operators who build this infrastructure now, before GLP-1 aligned programming becomes a standard expectation, will hold a structural advantage through 2027 and beyond. Early movers in clinical-adjacent fitness positioning tend to capture the physician referral relationships that become sticky over time. A GP who sends their first GLP-1 patient to your facility and sees good outcomes will keep sending patients.
What You Should Be Doing Right Now
If you're running a gym and you haven't yet thought about how GLP-1 users fit into your member acquisition and retention strategy, here's where to start:
- Audit your current programming for resistance training depth. If your class schedule is cardio-heavy and your strength offering is minimal, you're not set up to serve this population effectively.
- Train at least two or three coaches specifically in GLP-1-adjacent protocols, including muscle preservation priorities, protein coaching basics, and how to communicate with medically informed clients.
- Build a one-page clinical partner document that you can share with local prescribers explaining your facility's capabilities and what outcomes members can expect.
- Create a tiered membership structure that bundles strength programming, nutrition coaching, and body composition tracking as a premium GLP-1 track priced at $300 to $450 per month.
- Measure body composition, not just attendance. GLP-1 users care about lean mass retention. If your facility can show month-over-month muscle data, you're providing something scale weight alone can't tell them.
The market dynamics are aligned in your favor. GLP-1 adoption is accelerating, the clinical case for structured exercise is solidifying, and the HFA has handed the industry a credible framework to use. Operators who treat this moment as a revenue architecture decision, not just a programming tweak, are the ones who will look back on 2026 as the year they got ahead of the curve.
The drugs are coming whether gyms are ready or not. The operators who position their facilities as the essential clinical companion to GLP-1 therapy are the ones who will capture this cohort. That positioning starts with the decisions you make in the next six months.